Humana stock analysis
Want to see HUM full AI Analyst Report?
Humana (HUM) Stock Price & Analysis
HUM Stock Chart & Stats
- Day’s Range
- $387.83 - $401.98
- 52-Week Range
- $163.11 - $462.87
- Previous Close
- $380.00
- Volume
- N/A
- Average Volume (3M)
- 1.67M
- Market Cap
- $46.84B
- Enterprise Value
- $59.05B
- Total Cash (Recent Filing)
- $25.11B
- Total Debt (Recent Filing)
- $12.50B
- Price to Earnings (P/E)
- 37.6
- Beta
- 1.02
- Next Earnings
- Feb 10, 2027 (Est.)
- EPS Estimate
- -7.58
- Next Dividend Ex-Date
- Dec 24, 2026
- Dividend Yield
- 0.91%
Bulls Say, Bears Say
Bulls Say
Strong Revenue Growth
Humana has continued expanding its revenue base despite slower growth than in earlier years. This scale reflects durable demand for Medicare-focused insurance and healthcare services, giving the company a broader membership and premium platform from which operating improvements can compound.
Medicare Advantage Quality Strength
Exceptional Stars performance strengthens Humana’s competitive position in Medicare Advantage because quality ratings influence bonus economics and enrollment appeal. A high share of members in 4+ Star plans can support revenue potential, product competitiveness, and future margin recovery.
CenterWell And Medicaid Expansion
Growth across CenterWell primary care and Medicaid broadens Humana beyond its established insurance base and increases exposure to care delivery and dual-eligible opportunities. The expansion also supports care coordination capabilities that can improve outcomes and manage total medical costs.
Bears Say
Material Profitability Compression
The sharp decline in net, EBIT, and EBITDA margins shows that revenue growth has not translated proportionally into earnings. Persistently lower profitability reduces internal funding capacity, weakens returns on equity, and leaves less room to absorb medical-cost pressure or execution setbacks.
Higher Medical And Pharmacy Cost Trends
Rising cost trends create a structural pressure on insurance margins because Humana must price benefits and manage care ahead of claims development. The especially high Part D outlook could raise pharmacy-related expenses and make the planned 2027 margin improvement more execution-dependent.
Volatile Cash Generation
The wide swings in operating and free cash flow make cash conversion less predictable than the revenue trajectory. Although TTM cash flow improved, inconsistent working-capital effects and an anomalous cash-flow-to-earnings relationship can constrain confidence in funding growth, debt actions, and shareholder returns.
HUM FAQ
What was Humana’s price range in the past 12 months?
What is Humana’s market cap?
When is Humana’s upcoming earnings report date?
How were Humana’s earnings last quarter?
Is Humana overvalued?
Does Humana pay dividends?
What is Humana’s EPS estimate?
How many shares outstanding does Humana have?
What happened to Humana’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Humana?
What is the TipRanks Smart Score and how is it calculated?
Humana Stock Smart Score
Company Description
Humana
Humana Inc., a prominent health and well-being enterprise, operates across the United States through its various subsidiary companies. Its operational structure is divided into three main segments: Retail, Group and Specialty, and Healthcare Services. The firm provides a wide array of medical and supplementary insurance plans directly to individual consumers. Furthermore, Humana collaborates with government entities; it holds a contract with the Centers for Medicare and Medicaid Services (CMS) to manage the Limited Income Newly Eligible Transition (LI NET) prescription drug program. The company also secures agreements with numerous states to deliver Medicaid, dual-eligible, and long-term care support benefits. For employer groups and individuals, Humana furnishes fully insured commercial medical and specialized health coverage, which encompasses dental, vision, and other ancillary health benefits. They additionally offer administrative services only (ASO) solutions and extend support to military personnel through contracts like the TRICARE T2017 East Region. Beyond insurance products, the company delivers comprehensive healthcare services directly. These include pharmacy management, provider network services, and a suite of home-based solutions such as home health care, serving both its own health plan enrollees and external clients. By the close of 2021 (December 31), Humana's reach extended to approximately 17 million individuals enrolled in its medical benefit plans and an additional 5 million utilizing its specialized product offerings. Established in 1961, Humana Inc. maintains its corporate headquarters in Louisville, Kentucky.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Plans
- CEO
- James A. Rechtin
- Employees
- 67,060
- Website
- www.humana.com
- Address
- Humana Building, Louisville, KY, 40202, US
Humana (HUM) Earnings & Revenues
HUM Earnings Call
Earnings Call SentimentPositive
The call was strongly positive. Humana raised its 2026 EPS outlook, reported better-than-expected cost performance, delivered exceptional Stars results, expanded Medicaid and CenterWell membership, improved balance sheet efficiency, and expressed confidence in 2027 margin progress and its 2028 commitments. The main challenges were the continuing Stars headwind, higher expected 2027 cost trends, localized Primary Care Organization pressure, and uncertainty around AEP retention and the eventual size of the 2028 tailwind.
View all HUM earnings summariesHUM Net sales Breakdown
- 94.73% Premiums
- 4.50% Services
- 0.78% Investment income
HUM Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 8 | 3 | 11 |
| Technical Analysis | 5 | 3 | 2 |
| Moving Averages | 3 | 0 | 9 |












